INAB vs AMGN: Which Stock is Better?
Side-by-side comparison of In8Bio Inc and Amgen Inc in 2026
INAB
In8Bio Inc
$1.40
AMGN
Amgen Inc
$348.22
Key Metrics Comparison
| Metric | INAB | AMGN | Winner |
|---|---|---|---|
| Market Cap | $13.29M | $189.19B | AMGN |
| P/E Ratio | N/A | 24.70 | AMGN |
| EPS (TTM) | $N/A | $14.21 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze INAB
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INAB or AMGN a better investment?
Comparing INAB and AMGN: In8Bio Inc has a market cap of $13.29M while Amgen Inc has $189.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INAB and AMGN?
INAB (In8Bio Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INAB or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INAB or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for INAB.
Which company is more profitable: INAB or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for INAB.
Which is the larger company: INAB or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $189.19B compared to $13.29M for INAB.
Should I buy INAB or AMGN in 2026?
Both INAB and AMGN have investment merit. INAB trades at $1.40 while AMGN trades at $348.22. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INAB and AMGN stock?
Key differences: Market Cap ($13.29M vs $189.19B), P/E Ratio (N/A vs 24.7x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).